{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:03:46Z","timestamp":1793721826361,"version":"4.6.1"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41584-021-00605-2","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T13:04:05Z","timestamp":1619615045000},"page":"333-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":310,"title":["Epithelial\u2013immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis"],"prefix":"10.1038","volume":"17","author":[{"given":"Gwenny M.","family":"Verstappen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0779-1680","authenticated-orcid":false,"given":"Sarah","family":"Pringle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G. M.","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"issue":"Suppl 2","key":"605_CR1","first-page":"1","volume":"11","author":"H Sj\u00f6gren","year":"1933","unstructured":"Sj\u00f6gren, H. Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei Hypofunktion der Tr\u00e4nendr\u00fcsen). Acta Ophthalmol. 11 (Suppl. 2), 1\u201351 (1933).","journal-title":"Acta Ophthalmol."},{"key":"605_CR2","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n, P. et al. Sj\u00f6gren syndrome. Nat. Rev. Dis. Primers 2, 16047 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"605_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski, C. H. et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 69, 35\u201345 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","volume":"37","author":"JS Greenspan","year":"1974","unstructured":"Greenspan, J. S., Daniels, T. E., Talal, N. & Sylvester, R. A. The histopathology of Sj\u00f6gren\u2019s syndrome in labial salivary gland biopsies. Oral Surg. Oral Med. Oral Pathol. 37, 217\u2013229 (1974).","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"605_CR5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"MI Christodoulou","year":"2010","unstructured":"Christodoulou, M. I., Kapsogeorgou, E. K. & Moutsopoulos, H. M. Characteristics of the minor salivary gland infiltrates in Sjogren\u2019s syndrome. J. Autoimmun. 34, 400\u2013407 (2010).","journal-title":"J. Autoimmun."},{"key":"605_CR6","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","volume":"103","author":"JE Gottenberg","year":"2006","unstructured":"Gottenberg, J. E. et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren\u2019s syndrome. Proc. Natl Acad. Sci. USA 103, 2770\u20132775 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"605_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","volume":"13","author":"M Bombardieri","year":"2017","unstructured":"Bombardieri, M., Lewis, M. & Pitzalis, C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat. Rev. Rheumatol. 13, 141\u2013154 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"605_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne, G. & Mariette, X. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 14, 133\u2013145 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"605_CR9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","volume":"10","author":"FG Kroese","year":"2014","unstructured":"Kroese, F. G. et al. B-cell hyperactivity in primary Sjogren\u2019s syndrome. Expert Rev. Clin. Immunol. 10, 483\u2013499 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"605_CR10","first-page":"s42","volume":"37","author":"MS van Ginkel","year":"2019","unstructured":"van Ginkel, M. S. et al. Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sj\u00f6gren\u2019s syndrome patients. Clin. Exp. Rheumatol. 37, s42\u2013s48 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"605_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s004280050347","volume":"434","author":"S Ihrler","year":"1999","unstructured":"Ihrler, S., Zietz, C., Sendelhofert, A., Riederer, A. & Lohrs, U. Lymphoepithelial duct lesions in Sjogren-type sialadenitis. Virchows Arch. 434, 315\u2013323 (1999).","journal-title":"Virchows Arch."},{"key":"605_CR12","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V","volume":"41","author":"P Tengn\u00e9r","year":"1998","unstructured":"Tengn\u00e9r, P., Halse, A., Haga, H., Jonsson, R. & Wahren-Herlenius, M. Detection of anti-Ro\/SSA and anti-La\/SSB autoantibody-producing cells in salivary glands from patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 41, 2238\u20132248 (1998).","journal-title":"Arthritis Rheum."},{"key":"605_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","volume":"51","author":"NC Kyriakidis","year":"2014","unstructured":"Kyriakidis, N. C., Kapsogeorgou, E. K. & Tzioufas, A. G. A comprehensive review of autoantibodies in primary Sj\u00f6gren\u2019s syndrome: Clinical phenotypes and regulatory mechanisms. J. Autoimmun. 51, 67\u201374 (2014).","journal-title":"J. Autoimmun."},{"key":"605_CR14","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","volume":"67","author":"E Theander","year":"2015","unstructured":"Theander, E. et al. Prediction of Sj\u00f6gren\u2019s Syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling. Arthritis Rheumatol. 67, 2427\u20132436 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0003-9969(73)90156-8","volume":"18","author":"C Dawes","year":"1973","unstructured":"Dawes, C. & Wood, C. M. The contribution of oral minor mucous gland secretions to the volume of whole saliva in man. Arch. Oral. Biol. 18, 337\u2013342 (1973).","journal-title":"Arch. Oral. Biol."},{"key":"605_CR16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/rheumatology\/32.7.578","volume":"32","author":"R Jonsson","year":"1993","unstructured":"Jonsson, R., Kroneld, U., Backman, K., Magnusson, M. & Tarkowskit, A. Progression of sialadenitis in Sj\u00f6gren\u2019s sydrome. Br. J. Rheumatol. 32, 578\u2013581 (1993).","journal-title":"Br. J. Rheumatol."},{"key":"605_CR17","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/art.30295","volume":"63","author":"AAM Bookman","year":"2011","unstructured":"Bookman, A. A. M. et al. Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sj\u00f6gren\u2019s syndrome but not patients with sicca. Arthritis Rheum. 63, 2014\u20132020 (2011).","journal-title":"Arthritis Rheum."},{"key":"605_CR18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.60.12.1110","volume":"60","author":"WW Kalk","year":"2001","unstructured":"Kalk, W. W. et al. Sialometry and sialochemistry: diagnostic tools for Sjogren\u2019s syndrome. Ann. Rheum. Dis. 60, 1110\u20131116 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6890-5-1","volume":"5","author":"AML Pedersen","year":"2005","unstructured":"Pedersen, A. M. L., Bardow, A. & Nauntofte, B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sj\u00f6gren\u2019s syndrome. BMC Clin. Pathol. 5, 1\u201313 (2005).","journal-title":"BMC Clin. Pathol."},{"key":"605_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0030-4220(76)90229-2","volume":"41","author":"ID Mandel","year":"1976","unstructured":"Mandel, I. D. & Baurmash, H. Sialochemistry in Sj\u00f6gren\u2019s syndrome. Oral Surgery Oral Med. Oral Pathol. 41, 182\u2013187 (1976).","journal-title":"Oral Surgery Oral Med. Oral Pathol."},{"key":"605_CR21","first-page":"299","volume":"33","author":"R Herrera-Esparza","year":"2020","unstructured":"Herrera-Esparza, R. et al. Apoptosis and cell proliferation: the paradox of salivary glands in Sj\u00f6gren\u2019s disease. Acta Reumatol. Port. 33, 299\u2013303 (2020).","journal-title":"Acta Reumatol. Port."},{"key":"605_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/labinvest.3780215","volume":"81","author":"M Ohlsson","year":"2001","unstructured":"Ohlsson, M., Skarstein, K., Bolstad, A. I., Johannessen, A. C. & Jonsson, R. Fas-induced apoptosis is a rare event in Sj\u00f6gren\u2019s syndrome. Lab. Invest. 81, 95\u2013105 (2001).","journal-title":"Lab. Invest."},{"key":"605_CR23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2249.1998.00705.x","volume":"114","author":"M Polihronis","year":"1998","unstructured":"Polihronis, M. et al. Modes of epithelial cell death and repair in Sjogren\u2019s syndrome (SS). Clin. Exp. Immunol. 114, 485\u2013490 (1998).","journal-title":"Clin. Exp. Immunol."},{"key":"605_CR24","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar2671","volume":"11","author":"M Calafat","year":"2009","unstructured":"Calafat, M. et al. Vasoactive intestinal peptide inhibits TNF-\u03b1-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands. Arthritis Res. Ther. 11, R53 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"605_CR25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaut.2016.07.006","volume":"75","author":"MJ Barrera","year":"2016","unstructured":"Barrera, M. J. et al. Pro-inflammatory cytokines enhance ERAD and ATF6\u03b1 pathway activity in salivary glands of Sj\u00f6gren\u2019s syndrome patients. J. Autoimmun. 75, 68\u201381 (2016).","journal-title":"J. Autoimmun."},{"key":"605_CR26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1874609808666150727112826","volume":"8","author":"H Bouma","year":"2015","unstructured":"Bouma, H. et al. Aging and immunopathology in primary Sj\u00f6gren\u2019s syndrome. Curr. Aging Sci. 8, 202\u2013213 (2015).","journal-title":"Curr. Aging Sci."},{"key":"605_CR27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.bbamcr.2018.07.002","volume":"1865","author":"I Ambudkar","year":"2018","unstructured":"Ambudkar, I. Calcium signaling defects underlying salivary gland dysfunction. Biochim. Biophys. Acta Mol. Cell Res. 1865, 1771\u20131777 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"605_CR28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","volume":"43","author":"SA Waterman","year":"2000","unstructured":"Waterman, S. A., Gordon, T. P. & Rischmueller, M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 43, 1647\u20131654 (2000).","journal-title":"Arthritis Rheum."},{"key":"605_CR29","volume":"5","author":"LY Teos","year":"2015","unstructured":"Teos, L. Y. et al. IP3R deficit underlies loss of salivary fluid secretion in Sj\u00f6gren\u2019s Syndrome. Sci. Rep. 5, 13953 (2015).","journal-title":"Sci. Rep."},{"key":"605_CR30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaut.2018.10.019","volume":"97","author":"J Cort\u00e9s","year":"2019","unstructured":"Cort\u00e9s, J. et al. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sj\u00f6gren\u2019s syndrome patients. J. Autoimmun. 97, 88\u201399 (2019).","journal-title":"J. Autoimmun."},{"key":"605_CR31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133497","volume":"5","author":"J Cortes-Troncoso","year":"2020","unstructured":"Cortes-Troncoso, J. et al. T cell exosome-derived miR-142-3p impairs glandular cell function in Sj\u00f6gren\u2019s syndrome. JCI Insight 5, e133497 (2020).","journal-title":"JCI Insight"},{"key":"605_CR32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2334\/josnusd.17-0150","volume":"60","author":"T Ichiyama","year":"2018","unstructured":"Ichiyama, T. et al. Expression of aquaporin 3 and 5 as a potential marker for distinguishing dry mouth from Sj\u00f6gren\u2019s syndrome. J. Oral Sci. 60, 212\u2013220 (2018).","journal-title":"J. Oral Sci."},{"key":"605_CR33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/00016357.2013.879995","volume":"72","author":"TB Enger","year":"2013","unstructured":"Enger, T. B., Aure, M. H., Jensen, J. L. & Galtung, H. K. Calcium signaling and cell volume regulation are altered in Sj\u00f6gren\u2019s syndrome. Acta Odontol. Scand. 72, 549\u2013556 (2013).","journal-title":"Acta Odontol. Scand."},{"key":"605_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00926038","volume":"137","author":"AM Wu","year":"1994","unstructured":"Wu, A. M., Csako, G. & Herp, A. Structure, biosynthesis, and function of salivary mucins. Mol. Cell. Biochem. 137, 39\u201355 (1994).","journal-title":"Mol. Cell. Biochem."},{"key":"605_CR35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/odi.12339","volume":"21","author":"HH Sung","year":"2015","unstructured":"Sung, H. H. et al. MUC1\/SEC and MUC1\/Y overexpression is associated with inflammation in Sj\u00f6gren\u2019s syndrome. Oral Dis. 21, 730\u2013738 (2015).","journal-title":"Oral Dis."},{"key":"605_CR36","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/rheumatology\/kev026","volume":"54","author":"MJ Barrera","year":"2015","unstructured":"Barrera, M. J. et al. Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sj\u00f6gren\u2019s syndrome? Rheumatology 54, 1518\u20131527 (2015).","journal-title":"Rheumatology"},{"key":"605_CR37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/ard.2004.033837","volume":"65","author":"C Molina","year":"2006","unstructured":"Molina, C. et al. Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sj\u00f6gren\u2019s syndrome: association with mononuclear cell infiltration. Ann. Rheum. Dis. 65, 178\u2013183 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/rheumatology\/kez316","volume":"59","author":"I Castro","year":"2020","unstructured":"Castro, I. et al. Aberrant MUC1 accumulation in salivary glands of Sj\u00f6gren\u2019s syndrome patients is reversed by TUDCA in vitro. Rheumatology 59, 742\u2013753 (2020).","journal-title":"Rheumatology"},{"key":"605_CR39","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1097\/ICO.0000000000002147","volume":"38","author":"VY Bunya","year":"2019","unstructured":"Bunya, V. Y. et al. Prevalence of novel candidate Sj\u00f6gren syndrome autoantibodies in the penn Sj\u00f6gren\u2019s international collaborative clinical alliance cohort. Cornea 38, 1500\u20131505 (2019).","journal-title":"Cornea"},{"key":"605_CR40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2014.08.009","volume":"155","author":"L Shen","year":"2014","unstructured":"Shen, L. et al. Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren\u2019s syndrome. Clin. Immunol. 155, 42\u201346 (2014).","journal-title":"Clin. Immunol."},{"key":"605_CR41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","volume":"145","author":"L Shen","year":"2012","unstructured":"Shen, L. et al. Novel autoantibodies in Sjogren\u2019s syndrome. Clin. Immunol. 145, 251\u2013255 (2012).","journal-title":"Clin. Immunol."},{"key":"605_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008058","volume":"15","author":"T Vila","year":"2019","unstructured":"Vila, T., Rizk, A. M., Sultan, A. S. & Jabra-Rizk, M. A. The power of saliva: antimicrobial and beyond. PLoS Pathog. 15, e1008058 (2019).","journal-title":"PLoS Pathog."},{"key":"605_CR43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/ard.2006.052647","volume":"66","author":"J Pijpe","year":"2007","unstructured":"Pijpe, J. et al. Progression of salivary gland dysfunction in patients with Sjogren\u2019s syndrome. Ann. Rheum. Dis. 66, 107\u2013112 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/ard.61.2.137","volume":"61","author":"WWI Kalk","year":"2002","unstructured":"Kalk, W. W. I. et al. Sialometry and sialochemistry: a non-invasive approach for diagnosing Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 61, 137\u2013144 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.1989.tb00765.x","volume":"18","author":"BE Kurth","year":"1989","unstructured":"Kurth, B. E., Hazen-Martin, D. J., Sens, M. A., DeChamplain, R. W. & Sens, D. A. Cell culture and characterization of human minor salivary gland duct cells. J. Oral Pathol. Med. 18, 214\u2013219 (1989).","journal-title":"J. Oral Pathol. Med."},{"key":"605_CR46","first-page":"311","volume":"18","author":"R Matsumura","year":"2020","unstructured":"Matsumura, R. et al. Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line. Clin. Exp. Rheumatol. 18, 311\u2013318 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"605_CR47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/jaut.2001.0524","volume":"17","author":"RF Abu-Helu","year":"2001","unstructured":"Abu-Helu, R. F., Dimitriou, I. D., Kapsogeorgou, E. K., Moutsopoulos, H. M. & Manoussakis, M. N. Induction of salivary gland epithelial cell injury in sjogren\u2019s syndrome: in vitro assessment of T cell-derived cytokines and fas protein expression. J. Autoimmun. 17, 141\u2013153 (2001).","journal-title":"J. Autoimmun."},{"key":"605_CR48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaut.2010.06.010","volume":"35","author":"MN Manoussakis","year":"2010","unstructured":"Manoussakis, M. N., Spachidou, M. P. & Maratheftis, C. I. Salivary epithelial cells from Sjogren\u2019s syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J. Autoimmun. 35, 212\u2013218 (2010).","journal-title":"J. Autoimmun."},{"key":"605_CR49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-3083.2002.01168.x","volume":"56","author":"M Ohlsson","year":"2002","unstructured":"Ohlsson, M., Szodoray, P., Loro, L. L., Johannessen, A. C. & Jonsson, R. CD40, CD154, Bax and Bcl-2 expression in Sjogren\u2019s syndrome salivary glands: a putative anti-apoptotic role during its effector phases. Scand. J. Immunol. 56, 561\u2013571 (2002).","journal-title":"Scand. J. Immunol."},{"key":"605_CR50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/art.20789","volume":"52","author":"L Ping","year":"2005","unstructured":"Ping, L., Ogawa, N. & Sugai, S. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 52, 573\u2013581 (2005).","journal-title":"Arthritis Rheum."},{"key":"605_CR51","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1196\/annals.1422.044","volume":"1108","author":"M Sisto","year":"2007","unstructured":"Sisto, M. et al. Autoantibodies from Sj\u00f6gren\u2019s syndrome trigger apoptosis in salivary gland cell line. Ann. NY Acad. Sci. 1108, 418\u2013425 (2007).","journal-title":"Ann. NY Acad. Sci."},{"key":"605_CR52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","volume":"35","author":"MN Manoussakis","year":"2010","unstructured":"Manoussakis, M. N. & Kapsogeorgou, E. K. The role of intrinsic epithelial activation in the pathogenesis of Sj\u00f6gren\u2019s syndrome. J. Autoimmun. 35, 219\u2013224 (2010).","journal-title":"J. Autoimmun."},{"key":"605_CR53","first-page":"1019","volume":"34","author":"A Kawakami","year":"2007","unstructured":"Kawakami, A. et al. Toll-like receptor in salivary glands from patients with Sj\u00f6gren\u2019s syndrome: functional analysis by human salivary gland cell line. J. Rheumatol. 34, 1019\u20131026 (2007).","journal-title":"J. Rheumatol."},{"key":"605_CR54","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2249.2006.03311.x","volume":"147","author":"MP Spachidou","year":"2007","unstructured":"Spachidou, M. P. et al. Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sj\u00f6gren\u2019s syndrome. Clin. Exp. Immunol. 147, 497\u2013503 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"605_CR55","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.176.4.2581","volume":"176","author":"P Sfriso","year":"2006","unstructured":"Sfriso, P. et al. Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren\u2019s syndrome, salivary glands. J. Immunol. 176, 2581\u20132589 (2006).","journal-title":"J. Immunol."},{"key":"605_CR56","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0","volume":"44","author":"G Xanthou","year":"2001","unstructured":"Xanthou, G. et al. \u2018Lymphoid\u2019 chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sj\u00f6gren\u2019s syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum. 44, 408\u2013418 (2001).","journal-title":"Arthritis Rheum."},{"key":"605_CR57","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","volume":"152","author":"RI Fox","year":"1994","unstructured":"Fox, R. I., Kang, H. I., Ando, D., Abrams, J. & Pisa, E. Cytokine mRNA expression in salivary gland biopsies of Sj\u00f6gren\u2019s syndrome. J. Immunol. 152, 5532\u20135539 (1994).","journal-title":"J. Immunol."},{"key":"605_CR58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/art.41558","volume":"73","author":"E Rivi\u00e8re","year":"2021","unstructured":"Rivi\u00e8re, E. et al. Interleukin-7\/interferon axis drives T-cell and salivary gland epithelial cell interactions in Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 73, 631\u2013640 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR59","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.immuni.2016.03.007","volume":"44","author":"VS Cortez","year":"2016","unstructured":"Cortez, V. S. et al. Transforming growth factor-\u03b2 signaling guides the differentiation of innate lymphoid cells in salivary glands. Immunity 44, 1127\u20131139 (2016).","journal-title":"Immunity"},{"key":"605_CR60","doi-asserted-by":"crossref","first-page":"eaaz4371","DOI":"10.1126\/sciimmunol.aaz4371","volume":"5","author":"B Stolp","year":"2020","unstructured":"Stolp, B. et al. Salivary gland macrophages and tissue-resident CD8+ T cells cooperate for homeostatic organ surveillance. Sci. Immunol. 5, eaaz4371 (2020).","journal-title":"Sci. Immunol."},{"key":"605_CR61","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/stem.2278","volume":"34","author":"S Pringle","year":"2016","unstructured":"Pringle, S. et al. Human salivary gland stem cells functionally restore radiation damaged salivary glands. Stem Cells 34, 640\u2013652 (2016).","journal-title":"Stem Cells"},{"key":"605_CR62","doi-asserted-by":"crossref","first-page":"101838","DOI":"10.1016\/j.isci.2020.101838","volume":"23","author":"BR Hauser","year":"2020","unstructured":"Hauser, B. R., Aure, M. H., Kelly, M. C., Hoffman, M. P. & Chibly, A. M. Generation of a single-cell RNAseq atlas of murine salivary gland development. iScience 23, 101838 (2020).","journal-title":"iScience"},{"key":"605_CR63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002063","volume":"3","author":"IM Lombaert","year":"2008","unstructured":"Lombaert, I. M. et al. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS ONE 3, e2063 (2008).","journal-title":"PLoS ONE"},{"key":"605_CR64","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26620","volume":"6","author":"E Emmerson","year":"2017","unstructured":"Emmerson, E. et al. SOX2 regulates acinar cell development in the salivary gland. eLife 6, e26620 (2017).","journal-title":"eLife"},{"key":"605_CR65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.stemcr.2015.11.009","volume":"6","author":"M Maimets","year":"2016","unstructured":"Maimets, M. et al. Long-term in vitro expansion of salivary gland stem cells driven by Wnt signals. Stem Cell Rep. 6, 150\u2013162 (2016).","journal-title":"Stem Cell Rep."},{"key":"605_CR66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.devcel.2015.02.013","volume":"33","author":"MH Aure","year":"2015","unstructured":"Aure, M. H., Konieczny, S. F. & Ovitt, C. E. Salivary gland homeostasis is maintained through acinar cell self-duplication. Dev. Cell 33, 231\u2013237 (2015).","journal-title":"Dev. Cell"},{"key":"605_CR67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gde.2015.01.007","volume":"32","author":"HR Kwon","year":"2015","unstructured":"Kwon, H. R. & Larsen, M. The contribution of specific cell subpopulations to submandibular salivary gland branching morphogenesis. Curr. Opin. Genet. Dev. 32, 47\u201354 (2015).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"605_CR68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/art.40659","volume":"71","author":"S Pringle","year":"2019","unstructured":"Pringle, S. et al. Salivary gland stem cells age prematurely in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 71, 133\u2013142 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR69","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/rheumatology\/keaa012","volume":"59","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sj\u00f6gren\u2019s syndrome. Rheumatology 59, 3003\u20133013 (2020).","journal-title":"Rheumatology"},{"key":"605_CR70","doi-asserted-by":"crossref","first-page":"17851","DOI":"10.3748\/wjg.v20.i47.17851","volume":"20","author":"KM Irvine","year":"2014","unstructured":"Irvine, K. M. et al. Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration. World J. Gastroenterol. 20, 17851\u201317862 (2014).","journal-title":"World J. Gastroenterol."},{"key":"605_CR71","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of cellular senescence. Trends Cell Biol. 28, 436\u2013453 (2018).","journal-title":"Trends Cell Biol."},{"key":"605_CR72","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813\u2013827 (2019).","journal-title":"Cell"},{"key":"605_CR73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/annrheumdis-2016-209595","volume":"76","author":"LC Cappelli","year":"2017","unstructured":"Cappelli, L. C. et al. Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab. Ann. Rheum. Dis. 76, 43\u201350 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR74","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1634\/theoncologist.2018-0823","volume":"24","author":"BM Warner","year":"2019","unstructured":"Warner, B. M. et al. Sicca syndrome associated with immune checkpoint inhibitor therapy. Oncologist 24, 1259\u20131269 (2019).","journal-title":"Oncologist"},{"key":"605_CR75","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.autrev.2018.01.010","volume":"17","author":"M Tocut","year":"2018","unstructured":"Tocut, M., Brenner, R. & Zandman-Goddard, G. Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors. Autoimmun. Rev. 17, 610\u2013616 (2018).","journal-title":"Autoimmun. Rev."},{"key":"605_CR76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","volume":"54","author":"JM Michot","year":"2016","unstructured":"Michot, J. M. et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur. J. Cancer 54, 139\u2013148 (2016).","journal-title":"Eur. J. Cancer"},{"key":"605_CR77","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/odi.13191","volume":"26","author":"D Sharma","year":"2020","unstructured":"Sharma, D. et al. Saliva microbiome in primary Sj\u00f6gren\u2019s syndrome reveals distinct set of disease-associated microbes. Oral. Dis. 26, 295\u2013301 (2020).","journal-title":"Oral. Dis."},{"key":"605_CR78","first-page":"4895","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou, S., Cai, Y., Wang, M., Yang, W. D. & Duan, N. Oral microbial flora of patients with Sicca syndrome. Mol. Med. Rep. 18, 4895\u20134903 (2018).","journal-title":"Mol. Med. Rep."},{"key":"605_CR79","volume":"6","author":"Z Zhou","year":"2018","unstructured":"Zhou, Z. et al. Molecular analysis of oral microflora in patients with primary Sj\u00f6gren\u2019s syndrome by using high-throughput sequencing. PeerJ 6, e5649 (2018).","journal-title":"PeerJ"},{"key":"605_CR80","doi-asserted-by":"crossref","first-page":"1660566","DOI":"10.1080\/20002297.2019.1660566","volume":"11","author":"ML Sembler-M\u00f8ller","year":"2019","unstructured":"Sembler-M\u00f8ller, M. L., Belstr\u00f8m, D., Locht, H., Enevold, C. & Pedersen, A. M. L. Next-generation sequencing of whole saliva from patients with primary Sj\u00f6gren\u2019s syndrome and non-Sj\u00f6gren\u2019s sicca reveals comparable salivary microbiota. J. Oral. Microbiol. 11, 1660566 (2019).","journal-title":"J. Oral. Microbiol."},{"key":"605_CR81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218319","volume":"14","author":"S Rusthen","year":"2019","unstructured":"Rusthen, S. et al. Dysbiotic salivary microbiota in dry mouth and primary Sj\u00f6gren\u2019s syndrome patients. PLoS ONE 14, e0218319 (2019).","journal-title":"PLoS ONE"},{"key":"605_CR82","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/rheumatology\/key215","volume":"57","author":"TA van der Meulen","year":"2018","unstructured":"van der Meulen, T. A. et al. Dysbiosis of the buccal mucosa microbiome in primary Sj\u00f6gren\u2019s syndrome patients. Rheumatology 57, 2225\u20132234 (2018).","journal-title":"Rheumatology"},{"key":"605_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key360","author":"ILA Bodewes","year":"2019","unstructured":"Bodewes, I. L. A., Bj\u00f6rk, A., Versnel, M. A. & Wahren-Herlenius, M. Innate immunity and interferons in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/key360 (2019).","journal-title":"Rheumatology"},{"key":"605_CR84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/ard.56.3.173","volume":"56","author":"M Garcia-Carrasco","year":"1997","unstructured":"Garcia-Carrasco, M. et al. Hepatitis C virus infection in \u2018primary\u2019 Sjogren\u2019s syndrome: prevalence and clinical significance in a series of 90 patients. Ann. Rheum. Dis. 56, 173\u2013175 (1997).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR85","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13075-015-0766-3","volume":"17","author":"P Brito-Zer\u00f3n","year":"2015","unstructured":"Brito-Zer\u00f3n, P. et al. How hepatitis C virus modifies the immunological profile of Sj\u00f6gren syndrome: analysis of 783 patients. Arthritis Res. Ther. 17, 250 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"605_CR86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","volume":"84","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals, M. et al. Sj\u00f6gren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine 84, 81\u201389 (2005).","journal-title":"Medicine"},{"key":"605_CR87","doi-asserted-by":"crossref","first-page":"197643","DOI":"10.1016\/j.virusres.2019.197643","volume":"269","author":"H Nakamura","year":"2019","unstructured":"Nakamura, H. et al. Initial human T-cell leukemia virus type 1 infection of the salivary gland epithelial cells requires a biofilm-like structure. Virus Res. 269, 197643 (2019).","journal-title":"Virus Res."},{"key":"605_CR88","first-page":"8402059","volume":"2016","author":"CM Lima","year":"2016","unstructured":"Lima, C. M. et al. Association of sicca syndrome with proviral load and proinflammatory cytokines in HTLV-1 infection. J. Immunol. Res. 2016, 8402059 (2016).","journal-title":"J. Immunol. Res."},{"key":"605_CR89","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/BOR.0000000000000289","volume":"28","author":"A Draborg","year":"2016","unstructured":"Draborg, A., Izarzugaza, J. M. G. & Houen, G. How compelling are the data for Epstein\u2013Barr virus being a trigger for systemic lupus and other autoimmune diseases? Curr. Opin. Rheumatol. 28, 398\u2013404 (2016).","journal-title":"Curr. Opin. Rheumatol."},{"key":"605_CR90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365513.2018.1550807","volume":"79","author":"L Sternb\u00e6k","year":"2019","unstructured":"Sternb\u00e6k, L. et al. Increased antibody levels to stage-specific Epstein\u2013Barr virus antigens in systemic autoimmune diseases reveal a common pathology. Scand. J. Clin. Lab. Invest. 79, 7\u201316 (2019).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"605_CR91","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3389\/fimmu.2019.01153","volume":"10","author":"A Sanosyan","year":"2019","unstructured":"Sanosyan, A. et al. Discrepancy of serological and molecular patterns of circulating Epstein-Barr virus reactivation in primary Sj\u00f6gren\u2019s syndrome. Front. Immunol. 10, 1153 (2019).","journal-title":"Front. Immunol."},{"key":"605_CR92","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0002-9343(91)90567-H","volume":"90","author":"X Mariette","year":"1991","unstructured":"Mariette, X., Gozlan, J., Clerc, D., Bisson, M. & Morinet, F. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with sj\u00f6gren\u2019s syndrome. Am. J. Med. 90, 286\u2013294 (1991).","journal-title":"Am. J. Med."},{"key":"605_CR93","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","volume":"66","author":"C Croia","year":"2014","unstructured":"Croia, C. et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 66, 2545\u20132557 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR94","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.virol.2009.03.030","volume":"388","author":"J Xiao","year":"2009","unstructured":"Xiao, J., Palefsky, J. M., Herrera, R., Berline, J. & Tugizov, S. M. EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells. Virology 388, 335\u2013343 (2009).","journal-title":"Virology"},{"key":"605_CR95","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ebiom.2016.06.041","volume":"10","author":"A Gallo","year":"2016","unstructured":"Gallo, A. et al. Targeting the Ca2+ sensor STIM1 by exosomal transfer of Ebv-miR-BART13-3p is associated with Sj\u00f6gren\u2019s syndrome. EBioMedicine 10, 216\u2013226 (2016).","journal-title":"EBioMedicine"},{"key":"605_CR96","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/BOR.0000000000000622","volume":"31","author":"M Ma\u015bli\u0144ska","year":"2019","unstructured":"Ma\u015bli\u0144ska, M. The role of Epstein-Barr virus infection in primary Sj\u00f6gren\u2019s syndrome. Curr. Opin. Rheumatol. 31, 475\u2013483 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"605_CR97","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/v11080762","volume":"11","author":"MK Smatti","year":"2019","unstructured":"Smatti, M. K. et al. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses 11, 762 (2019).","journal-title":"Viruses"},{"key":"605_CR98","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","volume":"11","author":"MT McClain","year":"2005","unstructured":"McClain, M. T. et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med. 11, 85\u201389 (2005).","journal-title":"Nat. Med."},{"key":"605_CR99","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00281-020-00793-1","volume":"42","author":"N Fischer","year":"2020","unstructured":"Fischer, N. Infection-induced epigenetic changes and their impact on the pathogenesis of diseases. Semin. Immunopathol. 42, 127\u2013130 (2020).","journal-title":"Semin. Immunopathol."},{"key":"605_CR100","volume":"13","author":"H Li","year":"2017","unstructured":"Li, H. et al. Identification of a Sj\u00f6gren\u2019s syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genet. 13, e1006820 (2017).","journal-title":"PLoS Genet."},{"key":"605_CR101","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","volume":"45","author":"CJ Lessard","year":"2013","unstructured":"Lessard, C. J. et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren\u2019s syndrome. Nat. Genet. 45, 1284\u20131292 (2013).","journal-title":"Nat. Genet."},{"key":"605_CR102","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1128\/JVI.02292-10","volume":"85","author":"L Liu","year":"2011","unstructured":"Liu, L. et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J. Virol. 85, 4025\u20134030 (2011).","journal-title":"J. Virol."},{"key":"605_CR103","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/0022034520918518","volume":"99","author":"J Xu","year":"2020","unstructured":"Xu, J., Li, Y., Gan, F., Du, Y. & Yao, Y. Salivary glands: potential reservoirs for COVID-19 asymptomatic infection. J. Dent. Res. 99, 989 (2020).","journal-title":"J. Dent. Res."},{"key":"605_CR104","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41586-020-2277-x","volume":"582","author":"N Kamitaki","year":"2020","unstructured":"Kamitaki, N. et al. Complement genes contribute sex-biased vulnerability in diverse disorders. Nature 582, 577\u2013581 (2020).","journal-title":"Nature"},{"key":"605_CR105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","volume":"8","author":"S Ghosh","year":"2008","unstructured":"Ghosh, S. & Hayden, M. S. New regulators of NF-\u03baB in inflammation. Nat. Rev. Immunol. 8, 837\u2013848 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"605_CR106","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/art.27362","volume":"62","author":"P Ewert","year":"2010","unstructured":"Ewert, P. et al. Disruption of tight junction structure in salivary glands from Sj\u00f6gren\u2019s syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum. 62, 1280\u20131289 (2010).","journal-title":"Arthritis Rheum."},{"key":"605_CR107","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/sji.12101","volume":"78","author":"G Nordmark","year":"2013","unstructured":"Nordmark, G. et al. Association of genes in the NF-\u03baB pathway with antibody-positive primary Sj\u00f6gren\u2019s syndrome. Scand. J. Immunol. 78, 447\u2013454 (2013).","journal-title":"Scand. J. Immunol."},{"key":"605_CR108","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10875-008-9212-5","volume":"28","author":"T-T Ou","year":"2008","unstructured":"Ou, T.-T. et al. IkB\u03b1 promoter polymorphisms in patients with primary Sj\u00f6gren\u2019s syndrome. J. Clin. Immunol. 28, 440\u2013444 (2008).","journal-title":"J. Clin. Immunol."},{"key":"605_CR109","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00418-011-0821-3","volume":"135","author":"M Sisto","year":"2011","unstructured":"Sisto, M. et al. A failure of TNFAIP3 negative regulation maintains sustained NF-\u03baB activation in Sj\u00f6gren\u2019s syndrome. Histochem. Cell Biol. 135, 615\u2013625 (2011).","journal-title":"Histochem. Cell Biol."},{"key":"605_CR110","volume":"13","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Dysregulation of NF-kB in glandular epithelial cells results in Sj\u00f6gren\u2019s-like features. PLoS ONE 13, e0200212 (2018).","journal-title":"PLoS ONE"},{"key":"605_CR111","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K. V., Deng, M. & Ting, J. P. Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"605_CR112","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-03231-w","volume":"591","author":"W-C Chou","year":"2021","unstructured":"Chou, W.-C. et al. AIM2 in regulatory T cells restrains autoimmune diseases. Nature 591, 300\u2013305 (2021).","journal-title":"Nature"},{"key":"605_CR113","doi-asserted-by":"crossref","first-page":"102381","DOI":"10.1016\/j.jaut.2019.102381","volume":"108","author":"AG Vakrakou","year":"2020","unstructured":"Vakrakou, A. G., Svolaki, I. P., Evangelou, K., Gorgoulis, V. G. & Manoussakis, M. N. Cell-autonomous epithelial activation of AIM2 (absent in melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary Sj\u00f6gren\u2019s syndrome. J. Autoimmun. 108, 102381 (2020).","journal-title":"J. Autoimmun."},{"key":"605_CR114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaut.2018.02.010","volume":"91","author":"AG Vakrakou","year":"2018","unstructured":"Vakrakou, A. G. et al. Systemic activation of NLRP3 inflammasome in patients with severe primary Sj\u00f6gren\u2019s syndrome fueled by inflammagenic DNA accumulations. J. Autoimmun. 91, 23\u201333 (2018).","journal-title":"J. Autoimmun."},{"key":"605_CR115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/joim.12115","volume":"274","author":"C Baldini","year":"2013","unstructured":"Baldini, C. et al. The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sj\u00f6gren\u2019s syndrome. J. Intern. Med. 274, 480\u2013489 (2013).","journal-title":"J. Intern. Med."},{"key":"605_CR116","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375\u2013386 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"605_CR117","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","volume":"56","author":"S Pestka","year":"1987","unstructured":"Pestka, S., Langer, J. A., Zoon, K. C. & Samuel, C. E. Interferons and their actions. Annu. Rev. Biochem. 56, 727\u2013777 (1987).","journal-title":"Annu. Rev. Biochem."},{"key":"605_CR118","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","volume":"75","author":"J Imgenberg-Kreuz","year":"2016","unstructured":"Imgenberg-Kreuz, J. et al. Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren\u2019s syndrome reveals regulatory effects at interferon-induced genes. Ann. Rheum. Dis. 75, 2029\u20132036 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR119","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","volume":"63","author":"A Nezos","year":"2015","unstructured":"Nezos, A. et al. Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis. J. Autoimmun. 63, 47\u201358 (2015).","journal-title":"J. Autoimmun."},{"key":"605_CR120","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","volume":"72","author":"Z Brkic","year":"2013","unstructured":"Brkic, Z. et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren\u2019s syndrome and association with disease activity and BAFF gene expression. Ann. Rheum. Dis. 72, 728\u2013735 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR121","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/annrheumdis-2019-216588","volume":"79","author":"E Rivi\u00e8re","year":"2020","unstructured":"Rivi\u00e8re, E. et al. Salivary gland epithelial cells from patients with Sj\u00f6gren\u2019s syndrome induce B-lymphocyte survival and activation. Ann. Rheum. Dis. 79, 1468\u20131477 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR122","doi-asserted-by":"crossref","first-page":"17609","DOI":"10.1073\/pnas.1209724109","volume":"109","author":"JC Hall","year":"2012","unstructured":"Hall, J. C. et al. Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc. Natl Acad. Sci. USA 109, 17609\u201317614 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"605_CR123","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2017.01.003","volume":"46","author":"A Brewitz","year":"2017","unstructured":"Brewitz, A. et al. CD8+ T cells orchestrate pDC-XCR1+ dendritic cell spatial and functional cooperativity to optimize priming. Immunity 46, 205\u2013219 (2017).","journal-title":"Immunity"},{"key":"605_CR124","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20020437","volume":"198","author":"B Vanbervliet","year":"2003","unstructured":"Vanbervliet, B. et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)\/CXCL12. J. Exp. Med. 198, 823\u2013830 (2003).","journal-title":"J. Exp. Med."},{"key":"605_CR125","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/art.21893","volume":"54","author":"T L\u00f6vgren","year":"2006","unstructured":"L\u00f6vgren, T. et al. Induction of interferon-\u03b1 by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sj\u00f6gren\u2019s syndrome auto antigen-associated RNA. Arthritis Rheum. 54, 1917\u20131927 (2006).","journal-title":"Arthritis Rheum."},{"key":"605_CR126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0714.2008.00700.x","volume":"38","author":"US Deshmukh","year":"2008","unstructured":"Deshmukh, U. S., Nandula, S. R., Thimmalapura, P.-R., Scindia, Y. M. & Bagavant, H. Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function. J. Oral. Pathol. Med. 38, 42\u201347 (2008).","journal-title":"J. Oral. Pathol. Med."},{"key":"605_CR127","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/eji.200738013","volume":"38","author":"M Ittah","year":"2008","unstructured":"Ittah, M. et al. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. Eur. J. Immunol. 38, 1058\u20131064 (2008).","journal-title":"Eur. J. Immunol."},{"key":"605_CR128","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/cei.12432","volume":"178","author":"NC Kyriakidis","year":"2014","unstructured":"Kyriakidis, N. C. et al. Toll-like receptor 3 stimulation promotes Ro52\/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway. Clin. Exp. Immunol. 178, 548\u2013560 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"605_CR129","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.39795","volume":"68","author":"CP Mavragani","year":"2016","unstructured":"Mavragani, C. P. et al. Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease. Arthritis Rheumatol. 68, 2686\u20132696 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2017.10.004","volume":"88","author":"CP Mavragani","year":"2018","unstructured":"Mavragani, C. P. et al. Defective regulation of L1 endogenous retroelements in primary Sjogren\u2019s syndrome and systemic lupus erythematosus: role of methylating enzymes. J. Autoimmun. 88, 75\u201382 (2018).","journal-title":"J. Autoimmun."},{"key":"605_CR131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaut.2018.02.007","volume":"90","author":"K Zhao","year":"2018","unstructured":"Zhao, K. et al. LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways. J. Autoimmun. 90, 105\u2013115 (2018).","journal-title":"J. Autoimmun."},{"key":"605_CR132","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.aac7442","volume":"350","author":"T Hung","year":"2015","unstructured":"Hung, T. et al. The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression. Science 350, 455\u2013459 (2015).","journal-title":"Science"},{"key":"605_CR133","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","volume":"179","author":"HJ Kong","year":"2007","unstructured":"Kong, H. J. et al. Cutting Edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 179, 26\u201330 (2007).","journal-title":"J. Immunol."},{"key":"605_CR134","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni.2548","volume":"14","author":"WA McEwan","year":"2013","unstructured":"McEwan, W. A. et al. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14, 327\u2013336 (2013).","journal-title":"Nat. Immunol."},{"key":"605_CR135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011776","volume":"5","author":"R Higgs","year":"2010","unstructured":"Higgs, R. et al. Self protection from anti-viral responses - Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-like receptors. PLoS ONE 5, e11776 (2010).","journal-title":"PLoS ONE"},{"key":"605_CR136","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.181.3.1780","volume":"181","author":"R Higgs","year":"2008","unstructured":"Higgs, R. et al. The E3 ubiquitin ligase Ro52 negatively regulates IFN-\u03b2 production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 181, 1780\u20131786 (2008).","journal-title":"J. Immunol."},{"key":"605_CR137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103609","volume":"9","author":"E Lazzari","year":"2014","unstructured":"Lazzari, E. et al. TRIpartite Motif 21 (TRIM21) differentially regulates the stability of interferon regulatory factor 5 (IRF5) Isoforms. PLoS ONE 9, e103609 (2014).","journal-title":"PLoS ONE"},{"key":"605_CR138","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","volume":"206","author":"A Espinosa","year":"2009","unstructured":"Espinosa, A. et al. Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J. Exp. Med. 206, 1661\u20131671 (2009).","journal-title":"J. Exp. Med."},{"key":"605_CR139","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2020.00098","volume":"11","author":"Y Kunishita","year":"2020","unstructured":"Kunishita, Y. et al. TRIM21 dysfunction enhances aberrant B-cell differentiation in autoimmune pathogenesis. Front. Immunol. 11, 98 (2020).","journal-title":"Front. Immunol."},{"key":"605_CR140","doi-asserted-by":"crossref","first-page":"36478","DOI":"10.1074\/jbc.M111.241786","volume":"286","author":"A Espinosa","year":"2011","unstructured":"Espinosa, A. et al. Anti-Ro52 autoantibodies from patients with Sj\u00f6gren\u2019s syndrome inhibit the Ro52 E3 ligase activity by blocking the E3\/E2 interface. J. Biol. Chem. 286, 36478\u201336491 (2011).","journal-title":"J. Biol. Chem."},{"key":"605_CR141","doi-asserted-by":"crossref","first-page":"E2142","DOI":"10.1073\/pnas.1513943113","volume":"113","author":"AJ Monteith","year":"2016","unstructured":"Monteith, A. J. et al. Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 113, E2142\u2013E2151 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"605_CR142","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001184","volume":"6","author":"MR Hillen","year":"2020","unstructured":"Hillen, M. R. et al. Autoantigen TRIM21\/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sj\u00f6gren\u2019s syndrome is associated with B cell hyperactivity and type i interferon activity. RMD Open 6, e001184 (2020).","journal-title":"RMD Open"},{"key":"605_CR143","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/art.10577","volume":"46","author":"N Ogawa","year":"2002","unstructured":"Ogawa, N., Ping, L., Zhenjun, L., Takada, Y. & Sugai, S. Involvement of the interferon-\u03b3-induced T cell-attracting chemokines, interferon-\u03b3-inducible 10-kd protein (CXCL10) and monokine induced by interferon-\u03b3 (CXCL9), in the salivary gland lesions of patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 46, 2730\u20132741 (2002).","journal-title":"Arthritis Rheum."},{"key":"605_CR144","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar1912","volume":"8","author":"M Ittah","year":"2006","unstructured":"Ittah, M. et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren\u2019s syndrome. Arthritis Res. Ther. 8, R51 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"605_CR145","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/art.40182","volume":"69","author":"SLM Blokland","year":"2017","unstructured":"Blokland, S. L. M. et al. Increased CCL25 and T helper cells expressing CCR9 in the salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome: potential new axis in lymphoid neogenesis. Arthritis Rheumatol. 69, 2038\u20132051 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR146","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","volume":"79","author":"E Pontarini","year":"2020","unstructured":"Pontarini, E. et al. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sj\u00f6gren\u2019s syndrome with ectopic germinal centres and MALT lymphoma. Ann. Rheum. Dis. 79, 1588\u20131599 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR147","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1529-0131(199902)42:2<229::AID-ANR4>3.0.CO;2-X","volume":"42","author":"MN Manoussakis","year":"1999","unstructured":"Manoussakis, M. N. et al. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 42, 229\u2013239 (1999).","journal-title":"Arthritis Rheum."},{"key":"605_CR148","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1365-2249.2002.01752.x","volume":"127","author":"ID Dimitriou","year":"2002","unstructured":"Dimitriou, I. D., Kapsogeorgou, E. K., Moutsopoulos, H. M. & Manoussakis, M. N. CD40 on salivary gland epithelial cells: High constitutive expression by cultured cells from Sj\u00f6gren\u2019s syndrome patients indicating their intrinsic activation. Clin. Exp. Immunol. 127, 386\u2013392 (2002).","journal-title":"Clin. Exp. Immunol."},{"key":"605_CR149","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko, S. V. et al. IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69\u201377 (2003).","journal-title":"Nat. Immunol."},{"issue":"Suppl 1","key":"605_CR150","first-page":"245","volume":"38","author":"E Apostolou","year":"2020","unstructured":"Apostolou, E. & Tzioufas, A. G. Type-III interferons in Sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. 38 (Suppl. 1), 245\u2013252 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"605_CR151","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12865","volume":"186","author":"E Apostolou","year":"2016","unstructured":"Apostolou, E. et al. Expression of type III interferons (IFN\u03bbs) and their receptor in Sj\u00f6gren\u2019s syndrome. Clin. Exp. Immunol. 186, 304\u2013312 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"605_CR152","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jaci.2016.01.024","volume":"137","author":"M Mingueneau","year":"2016","unstructured":"Mingueneau, M. et al. Cytometry by time-of-flight immunophenotyping identifies a blood Sj\u00f6gren\u2019s signature correlating with disease activity and glandular inflammation. J. Allergy Clin. Immunol. 137, 1809\u20131821.e12 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"605_CR153","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4049\/jimmunol.166.5.3107","volume":"166","author":"EK Kapsogeorgou","year":"2001","unstructured":"Kapsogeorgou, E. K., Moutsopoulos, H. M. & Manoussakis, M. N. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J. Immunol. 166, 3107\u20133113 (2001).","journal-title":"J. Immunol."},{"key":"605_CR154","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2013.11.003","volume":"51","author":"Y-Z Gong","year":"2014","unstructured":"Gong, Y.-Z. et al. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sj\u00f6gren\u2019s syndrome. J. Autoimmun. 51, 57\u201366 (2014).","journal-title":"J. Autoimmun."},{"key":"605_CR155","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3899\/jrheum.110097","volume":"39","author":"P Li","year":"2012","unstructured":"Li, P. et al. p38 mitogen-activated protein kinase and nuclear factor-kB facilitate CD40-mediated salivary epithelial cell death. J. Rheumatol. 39, 1256\u20131264 (2012).","journal-title":"J. Rheumatol."},{"key":"605_CR156","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2018.09.002","volume":"55","author":"BE Jones","year":"2018","unstructured":"Jones, B. E., Maerz, M. D. & Buckner, J. H. IL-6: a cytokine at the crossroads of autoimmunity. Curr. Opin. Immunol. 55, 9\u201314 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"605_CR157","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/art.40424","volume":"70","author":"VR Fonseca","year":"2018","unstructured":"Fonseca, V. R. et al. Ratio of blood T follicular regulatory cells to T follicular helper cells marks ectopic lymphoid structure formation while activated follicular helper T cells indicate disease activity in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 70, 774\u2013784 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR158","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/art.40488","volume":"70","author":"GM Verstappen","year":"2018","unstructured":"Verstappen, G. M. et al. Is the T follicular regulatory\/T follicular helper cell ratio in blood a biomarker for ectopic lymphoid structure formation in Sj\u00f6gren\u2019s syndrome? Arthritis Rheumatol. 70, 1354\u20131355 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","volume":"24","author":"F Carrette","year":"2012","unstructured":"Carrette, F. & Surh, C. D. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin. Immunol. 24, 209\u2013217 (2012).","journal-title":"Semin. Immunol."},{"key":"605_CR160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/art.27318","volume":"62","author":"A Bikker","year":"2010","unstructured":"Bikker, A. et al. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome correlates with increased inflammation. Arthritis Rheum. 62, 969\u2013977 (2010).","journal-title":"Arthritis Rheum."},{"key":"605_CR161","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.38007","volume":"65","author":"JO Jin","year":"2013","unstructured":"Jin, J. O., Kawai, T., Cha, S. & Yu, Q. Interleukin-7 enhances the Th1 response to promote the development of Sj\u00f6gren\u2019s syndrome-like autoimmune exocrinopathy in mice. Arthritis Rheum. 65, 2132\u20132142 (2013).","journal-title":"Arthritis Rheum."},{"key":"605_CR162","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/annrheumdis-2011-200744","volume":"71","author":"A Bikker","year":"2012","unstructured":"Bikker, A. et al. Increased interleukin (IL)-7R\u03b1 expression in salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity. Ann. Rheum. Dis. 71, 1027\u20131033 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR163","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","volume":"168","author":"G Nocturne","year":"2015","unstructured":"Nocturne, G. & Mariette, X. Sjogren Syndrome-associated lymphomas: an update on pathogenesis and management. Br. J. Haematol. 168, 317\u2013327 (2015).","journal-title":"Br. J. Haematol."},{"key":"605_CR164","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.22458","volume":"56","author":"C Daridon","year":"2007","unstructured":"Daridon, C. et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 56, 1134\u20131144 (2007).","journal-title":"Arthritis Rheum."},{"key":"605_CR165","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","volume":"192","author":"M Batten","year":"2000","unstructured":"Batten, M. et al. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192, 1453\u20131465 (2000).","journal-title":"J. Exp. Med."},{"key":"605_CR166","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay, F. & Schneider, P. Cracking the BAFF code. Nat. Rev. Immunol. 9, 491\u2013502 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"605_CR167","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/art.40589","volume":"70","author":"J Lee","year":"2018","unstructured":"Lee, J. et al. JAK-1 inhibition suppresses interferon-induced BAFF production in human salivary gland: potential therapeutic strategy for primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 70, 2057\u20132066 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR168","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaut.2013.02.002","volume":"41","author":"Y Thabet","year":"2013","unstructured":"Thabet, Y. et al. Epigenetic dysregulation in salivary glands from patients with primary Sj\u00f6gren\u2019s syndrome may be ascribed to infiltrating B cells. J. Autoimmun. 41, 175\u2013181 (2013).","journal-title":"J. Autoimmun."},{"key":"605_CR169","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2017.03.012","volume":"81","author":"EA Haacke","year":"2017","unstructured":"Haacke, E. A. et al. FcRL4+ B-cells in salivary glands of primary Sj\u00f6gren\u2019s syndrome patients. J. Autoimmun. 81, 90\u201398 (2017).","journal-title":"J. Autoimmun."},{"key":"605_CR170","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3389\/fimmu.2020.01486","volume":"11","author":"A Visser","year":"2020","unstructured":"Visser, A. et al. Repertoire analysis of B-cells located in striated ducts of salivary glands of patients With Sj\u00f6gren\u2019s syndrome. Front. Immunol. 11, 1486 (2020).","journal-title":"Front. Immunol."},{"key":"605_CR171","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179793","volume":"12","author":"M Jourdan","year":"2017","unstructured":"Jourdan, M. et al. Characterization of human FCRL4-positive B cells. PLoS ONE 12, e0179793 (2017).","journal-title":"PLoS ONE"},{"key":"605_CR172","doi-asserted-by":"crossref","first-page":"102439","DOI":"10.1016\/j.jaut.2020.102439","volume":"109","author":"GM Verstappen","year":"2020","unstructured":"Verstappen, G. M. et al. Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sj\u00f6gren\u2019s syndrome reveals a pathogenic signature. J. Autoimmun. 109, 102439 (2020).","journal-title":"J. Autoimmun."},{"key":"605_CR173","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1084\/jem.20151724","volume":"213","author":"SW Jackson","year":"2016","unstructured":"Jackson, S. W. et al. B cell IFN-\u03b3 receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J. Exp. Med. 213, 733\u2013750 (2016).","journal-title":"J. Exp. Med."},{"key":"605_CR174","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.20151722","volume":"213","author":"PP Domeier","year":"2016","unstructured":"Domeier, P. P. et al. IFN-\u03b3 receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity. J. Exp. Med. 213, 715\u2013732 (2016).","journal-title":"J. Exp. Med."},{"key":"605_CR175","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.4049\/jimmunol.1600652","volume":"197","author":"D Vijayan","year":"2016","unstructured":"Vijayan, D. et al. IL-27 directly enhances germinal center B cell activity and potentiates lupus in sanroque mice. J. Immunol. 197, 3008\u20133017 (2016).","journal-title":"J. Immunol."},{"key":"605_CR176","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.4049\/jimmunol.173.4.2479","volume":"173","author":"T Yoshimoto","year":"2004","unstructured":"Yoshimoto, T. et al. Induction of IgG2a class switching in B cells by IL-27. J. Immunol. 173, 2479\u20132485 (2004).","journal-title":"J. Immunol."},{"key":"605_CR177","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739.e6 (2018).","journal-title":"Immunity"},{"key":"605_CR178","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE. Nat. Commun. 9, 1758 (2018).","journal-title":"Nat. Commun."},{"key":"605_CR179","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1182\/blood-2011-05-353102","volume":"118","author":"HW Sohn","year":"2011","unstructured":"Sohn, H. W., Krueger, P. D., Davis, R. S. & Pierce, S. K. FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood 118, 6332\u20136341 (2011).","journal-title":"Blood"},{"key":"605_CR180","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1136\/annrheumdis-2015-208304","volume":"75","author":"K Delli","year":"2016","unstructured":"Delli, K. et al. Towards personalised treatment in primary Sj\u00f6gren\u2019s syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment. Ann. Rheum. Dis. 75, 1933\u20131938 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"605_CR181","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaut.2015.11.002","volume":"67","author":"D Cornec","year":"2016","unstructured":"Cornec, D. et al. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sj\u00f6gren\u2019s syndrome. J. Autoimmun. 67, 102\u2013110 (2016).","journal-title":"J. Autoimmun."},{"key":"605_CR182","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer, J. M. et al. Effectiveness of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 62, 960\u2013968 (2010).","journal-title":"Arthritis Rheum."},{"key":"605_CR183","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","volume":"160","author":"V Devauchelle-Pensec","year":"2014","unstructured":"Devauchelle-Pensec, V. et al. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann. Intern. Med. 160, 233\u2013242 (2014).","journal-title":"Ann. Intern. Med."},{"key":"605_CR184","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.40093","volume":"69","author":"SJ Bowman","year":"2017","unstructured":"Bowman, S. J. et al. Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 69, 1440\u20131450 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR185","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20072682","volume":"205","author":"GRA Ehrhardt","year":"2008","unstructured":"Ehrhardt, G. R. A. et al. Discriminating gene expression profiles of memory B cell subpopulations. J. Exp. Med. 205, 1807\u20131817 (2008).","journal-title":"J. Exp. Med."},{"key":"605_CR186","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4049\/jimmunol.1500368","volume":"197","author":"J Wherry","year":"2016","unstructured":"Wherry, J. et al. Viral infection expression is required to control chronic intrinsic T-bet \u2014 cutting edge: B cell. J. Immunol. 197, 1017\u20131022 (2016).","journal-title":"J. Immunol."},{"key":"605_CR187","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20171738","volume":"215","author":"\u00c1F \u00c1lvarez-Prado","year":"2018","unstructured":"\u00c1lvarez-Prado, \u00c1. F. et al. A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets. J. Exp. Med. 215, 761\u2013771 (2018).","journal-title":"J. Exp. Med."},{"key":"605_CR188","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/art.41263","volume":"72","author":"RJ Bende","year":"2020","unstructured":"Bende, R. J. et al. Salivary gland MALT lymphomas of Sj\u00f6gren\u2019s syndrome patients in majority express rheumatoid factors affinity-selected for IgG. Arthritis Rheumatol. 72, 1330\u20131340 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR189","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","volume":"127","author":"E Zucca","year":"2016","unstructured":"Zucca, E. & Bertoni, F. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood 127, 2082\u20132092 (2016).","journal-title":"Blood"},{"key":"605_CR190","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","volume":"201","author":"RJ Bende","year":"2005","unstructured":"Bende, R. J. et al. Among B cell non-Hodgkin\u2019s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201, 1229\u20131241 (2005).","journal-title":"J. Exp. Med."},{"key":"605_CR191","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cell.2020.01.029","volume":"180","author":"M Singh","year":"2020","unstructured":"Singh, M. et al. Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody. Cell 180, 878\u2013894.e19 (2020).","journal-title":"Cell"},{"key":"605_CR192","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/art.37828","volume":"65","author":"D Saadoun","year":"2013","unstructured":"Saadoun, D. et al. Expansion of autoreactive unresponsive CD21-\/low B cells in sj\u00f6gren\u2019s syndrome-associated lymphoproliferation. Arthritis Rheum. 65, 1085\u20131096 (2013).","journal-title":"Arthritis Rheum."},{"key":"605_CR193","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/art.40352","volume":"70","author":"S Glauzy","year":"2018","unstructured":"Glauzy, S. et al. Accumulation of antigen-driven lymphoproliferations in complement receptor 2\/CD21\u2212\/low B cells from patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 70, 298\u2013307 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR194","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/imr.12741","volume":"288","author":"SA Jenks","year":"2019","unstructured":"Jenks, S. A., Cashman, K. S., Woodruff, M. C., Lee, F. E. & Sanz, I. Extrafollicular responses in humans and SLE. Immunol. Rev. 288, 136\u2013148 (2019).","journal-title":"Immunol. Rev."},{"key":"605_CR195","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.39002","volume":"67","author":"RJ Bende","year":"2015","unstructured":"Bende, R. J. et al. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 67, 1074\u20131083 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"605_CR196","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2018.00491","volume":"9","author":"A Visser","year":"2018","unstructured":"Visser, A. et al. Acquisition of N-glycosylation sites in immunoglobulin heavy chain genes during local expansion in parotid salivary glands of primary Sj\u00f6gren patients. Front. Immunol. 9, 491 (2018).","journal-title":"Front. Immunol."},{"key":"605_CR197","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.20050630","volume":"202","author":"CM Lau","year":"2005","unstructured":"Lau, C. M. et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement. J. Exp. Med. 202, 1171\u20131177 (2005).","journal-title":"J. Exp. Med."},{"key":"605_CR198","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-3083.1999.00524.x","volume":"50","author":"Potter, K. N.","year":"1999","unstructured":"Potter, K. N., Li, Y., Mageed, R. A., Jefferis, R. & Capra, J. D. Molecular characterization of the VH1-specific variable region determinants recognized by anti-idiotypic monoclonal antibodies G6 and G8. Scand. J. Immunol. 50, 14\u201320 (1999).","journal-title":"Scand. J. Immunol."},{"key":"605_CR199","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","volume":"122","author":"G Nocturne","year":"2013","unstructured":"Nocturne, G. et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sj\u00f6gren\u2019s syndrome. Blood 122, 4068\u20134076 (2013).","journal-title":"Blood"},{"key":"605_CR200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/odi.13062","volume":"25","author":"LA Gueiros","year":"2019","unstructured":"Gueiros, L. A. et al. World workshop on oral medicine VII: immunobiologics for salivary gland disease in Sj\u00f6gren\u2019s syndrome: a systematic review. Oral. Dis. 25, 102\u2013110 (2019).","journal-title":"Oral. Dis."},{"key":"605_CR201","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/13543784.2019.1631796","volume":"28","author":"S Pringle","year":"2019","unstructured":"Pringle, S. et al. Small-molecule inhibitors and the salivary gland epithelium in Sj\u00f6gren\u2019s syndrome. Expert Opin. Investig. Drugs 28, 605\u2013616 (2019).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"605_CR202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor, C. et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583, 127 (2020).","journal-title":"Nature"},{"key":"605_CR203","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fonc.2020.00420","volume":"10","author":"S Pringle","year":"2020","unstructured":"Pringle, S. et al. Lack of conventional acinar cells in parotid salivary gland of patient taking an anti-PD-L1 immune checkpoint inhibitor. Front. Oncol. 10, 420 (2020).","journal-title":"Front. Oncol."},{"key":"605_CR204","first-page":"253","volume":"126","author":"S Pringle","year":"2020","unstructured":"Pringle, S., Wang, X., Vissink, A., Bootsma, H. & Kroese, F. G. M. Checkpoint inhibition-induced sicca: a type II interferonopathy? Clin. Exp. Rheumatol. 126, 253\u2013260 (2020).","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00605-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:42:24Z","timestamp":1733938944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00605-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":204,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1038\/s41584-021-00605-2","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"15 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}